Publications

Sort by: Date | Author | Title

Bock, C., Halbritter, F., Carmona, F. J., Tierling, S., Datlinger, P., Assenov, Y., Berdasco, M., Bergmann, A. K., Booher, K., Busato, F., Campan, M., Dahl, C., Dahmcke, C. M., Diep, D., Fernández, A. F., Gerhauser, C., Haake, A., Heilmann, K., Holcomb, T. ... Zhang, K. (2016). Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nature Biotechnology, 34(7), 726-737. https://doi.org/10.1038/nbt.3605
Bøttger, P., Pedersen, S. G., Gesslein, B., Illarionova, N., Isaksen, T. J., Heuck, A., Clausen, B. H., Füchtbauer, E.-M., Gramsbergen, J. B., Gunnarson, E., Aperia, A., Lauritzen, M., Lambertsen, K. L., Nissen, P. & Lykke-Hartmann, K. (2016). Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model. Scientific Reports, 6(22047), Article 22047. https://doi.org/10.1038/srep22047
Brøsen, K., Andersen, S. E., Borregaard, J., Christensen, H. R., Christensen, P. M., Dalhoff, K. P., Damkier, P., Hallas, J., Heisterberg, J., Jessen, N., Jürgens, G., Kampmann, J. P. K., Laursen, B. E., Laursen, T., Nielsen, L. P., Poulsen, B. K., Poulsen, H. E., Andersen, L. V., Senderovitz, T. & Sonne, J. (2016). Clinical Pharmacology in Denmark in 2016 - 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical Speciality. Basic & Clinical Pharmacology & Toxicology, 119(6), 523-532. https://doi.org/10.1111/bcpt.12681
Brüggemann, H. (2016). The emerging role of propionibacteria in human health and disease. In The Human Microbiota and Chronic Disease: Dysbiosis as a Cause of Human Pathology (pp. 199-214). John Wiley & Sons. https://doi.org/10.1002/9781118982907.ch12
Burt, S. A., Adolfse, S. J. M., Ahad, D. S. A., Tersteeg-Zijderveld, M. H. G., Jongerius-Gortemaker, B. G. M., Post, J. A., Brüggemann, H. & Santos, R. R. (2016). Cinnamaldehyde, Carvacrol and Organic Acids Affect Gene Expression of Selected Oxidative Stress and Inflammation Markers in IPEC-J2 Cells Exposed to Salmonella typhimurium. Phytotherapy Research, 30(12), 1988-2000. https://doi.org/10.1002/ptr.5705
Cabrera, S. M., Wang, X., Chen, Y.-G., Jia, S., Kaldunski, M. L., Greenbaum, C. J., Mandrup-Poulsen, T., Hessner, M. J., Type 1 Diabetes TrialNet Canakinumab Study Group & Rungby, J. (2016). Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset. European Journal of Immunology, 46(4), 1030-1046. https://doi.org/10.1002/eji.201546005